Introgen Presents Preclinical Data on INGN 251 at American Society of Gene Therapy Meeting
(PR Newswire)...The PTEN tumor suppressor gene is frequently mutated or not present in multiple......have already been made following PTEN gene transfer into models of brain, colorectal and endometrial cancer.......candidate, INGN 241 (Adenoviral-mda7), for the treatment of solid tumors, is in Phase I clinical development....- Jun 02 7:30 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010602/dasa001.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines